In This Issue/Research Watch/News in Brief/News from the IASLC Tobacco Control Committee
The 2015 World Health Organization Classification of Tumors of the Thymus
BRAF Alterations as Therapeutic Targets in Non–Small-Cell Lung Cancer
Racial Disparities in Health-Related Quality of Life After Lung Cancer Surgery
Estrogen Receptor Gene Polymorphisms and Lung Adenocarcinoma Risk in Never-Smoking Women
Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non–Small-Cell Lung Cancer
Somatic Mutation Spectrum of Non–Small-Cell Lung Cancer in African Americans
Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients
Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer
Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non–Small-Cell Lung Cancer
Evaluating Cryoablation of Metastatic Lung Tumors in Patients—Safety and Efficacy
Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0–2) Non–Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response
Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
Conditional Survival of Esophageal Cancer
Cystic Mediastinal Thymic Lymphangioma Mimicking Echinococcal Cyst
Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells
A Rare Subglottic Capillary Hemangioma
Durable Response to Tyrosine Kinase Inhibitor Therapy in a Lung Cancer Patient Harboring Epidermal Growth Factor Receptor Tandem Kinase Domain Duplication
Central Nervous System Pseudoprogression in a Patient Treated with PD-1 Checkpoint Inhibitor
Prognostic Value of FDG Uptake in Stage I Non–Small-Cell Lung Cancer
Reply to “Prognostic Value of Fluorodeoxyglucose-Positron Emission Tomography”
Amplification of MET in a Patient with Malignant Pleural Mesothelioma
A Case of Atypical Carcinoid
Next Generation Sequencing Uncovers Potential Genetic Driver Mutations of Malignant Pulmonary Granular Cell Tumor